<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Cerebral blood flow changes by argatroban in the <z:hpo ids='HP_0011009'>acute</z:hpo> stage of <z:hpo ids='HP_0005305'>cerebral thrombosis</z:hpo> have been investigated with the use of stable <z:chebi fb="3" ids="49957">xenon</z:chebi> computed tomography (Xe/CT) </plain></SENT>
<SENT sid="1" pm="."><plain>The study group consisted of 14 cases (7 males, 7 females) with the average age of 59 years old (ranging from 21 to 79 years of age) </plain></SENT>
<SENT sid="2" pm="."><plain>We evaluated the cerebral blood flow change after an intravenous drip infusion of 10 mg of argatroban </plain></SENT>
<SENT sid="3" pm="."><plain>After the administration of argatroban, we recognized a significant increase in the blood flow (24.4 +/- 5.0 ml/100 g/min to 28.4 +/- 2.7 ml/100 g/min, p &lt; 0.05) in the blood flow area of lower than 30 ml/100 g/min in the affected vascular territory </plain></SENT>
<SENT sid="4" pm="."><plain>As a conclusion, we found that argatroban improves ischemic symptoms through the amelioration of blood flow in the penumbra area </plain></SENT>
</text></document>